BSESangam Health Care Products LtdMinimalNeutral
Announced Wed, 15 Apr · 15:24 IST

Compliance certificate for Q4 FY26 under SEBI Reg 74(5)

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sangam Health Care Products has submitted a routine compliance certificate under SEBI's Depositories Regulations 74(5) for the quarter and year ended 31 March 2026. The certificate, backed by Registrar XL Softech Systems, confirms that all share certificates received for dematerialisation during the quarter were verified, mutilated, cancelled, and the depository's name was recorded as the registered owner within the required 30-day timeline. No share count or transaction data is disclosed.

Likely market impact

Routine regulatory filing with no material impact on shareholders or stock price. Standard RTA compliance confirmation.